The Oswaldo Cruz Foundation (Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America.
Its collaborative and open access Hub at TGHN aims to strengthen networks and improve capacities for public health research regionally and globally, by providing a vibrant virtual environment where professionals, students and researchers can share experiences, knowledge, resources and research tools.
Fiocruz is affiliated to the Brazilian Ministry of Health, and its mission is to produce, disseminate and share knowledge and technologies, aiming at strengthening and consolidating the Unified Health System (SUS, acronym in Portuguese for the Brazilian public health system) and the promotion of health and quality of life for the population.
Here, you can benefit from Fiocruz expertise in education to access the e-learning courses that have qualified over 1,8 million Brazilian health professionals. You also find publications with the most recent research findings, as well as information and news about Fiocruz.
Abstract In Brazil, Zika is framed as a virus transmitted only by mosquitoes and the epidemic as a concern only for women. In order to examine this misconception, this article investigates the ...
Abstract Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), may elicit uncontrolled and damaging inflammatory reactions, due to an excessive immune ...
Abstract Background South America is the current epicenter of COVID-19 pandemic. Yet, the epidemiological and clinical features of the disease have not been described in Brazil, the third most affected ...
Abstract Coronavirus disease 2019 (COVID-19) was initially described as a viral infection of the respiratory tract. It is now known, however, that many other biological systems are affected, including the ...
Since 2015 Brazil has experienced the social repercussions of the Zika virus epidemic, thus raising a debate about: difficulties of diagnosis; healthcare access for children with Zika Congenital Syndrome (ZCS); ...
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The impacts of the disease may be beyond the respiratory system, also affecting mental health. ...
Epidemics occur within the existing ecosystem of socioeconomic determinants of health, including class, gender, race, income, employment and individuals’ physical environment. The Zika virus epidemic (2014–2017) demonstrated disproportionate effects of ...
Abstract Data is becoming ever more critical and valuable for both scientists and health authorities searching for answers to the COVID-19 crisis. Due to difficulties in diagnosing this infection in ...
The 2015 to 2017 outbreak of Zika generated global attention on the risk of a spectrum of neurological disorders posed to women and their unborn children—including, but not limited to, ...
Abstract Background Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination. ...
On March 11th, 2020, the World Health Organization (WHO) declared COVID-19 (the disease caused by the novel coronavirus SARS-CoV-2) a pandemic. As of this article's writing, more than 1.3 million ...
The emergence of Zika virus in 2015 challenged conventional ideas of mosquito-borne diseases, tested the resilience of health systems and embedded itself within local sociocultural worlds, with major implications for ...
The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary ...
Saiba mais sobre a parceria Fiocruz+Universidade de Oxford para a produção de uma vacina contra a COVID-19
24/09/2020 Regina Castro In October, Fiocruz and the Murdoch Children’s Research Institute, in Australia, will begin testing the BCG vaccine (normally used to prevent tuberculosis) on healthcare professionals, to verify the protection of the immunizer against Covid-19 as well. The ... Read more
11/09/2020 Fiocruz Minas Researchers of Fiocruz and Visuri, reference institutions in research and development of technology for health, have developed a portable device, the OmniLAMP, for the molecular diagnosis of COVID-19 through the detection of SARS-CoV-2 genetic material. Using the ... Read more
13/10/2020 Gardênia Vargas (CDTS/Fiocruz) The Center for Technological Development in Health of the Oswaldo Cruz Foundation (CDTS/Fiocruz) and the European Infrastructure for Translational Medicine (Eatris) signed, in September, a letter of intent with the goal of promoting initiatives in translational ... Read more
07/10/2020 Maíra Menezes (IOC/Fiocruz) In a partnership with the National Institute of Metrology, Quality, and Technology (Inmetro), researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) have recorded new images that reveal the effects of the infection by the new coronavirus in ... Read more
24/09/2020 Regina Castro In October, Fiocruz and the Murdoch Children’s Research Institute, in Australia, will begin testing the BCG vaccine (normally used to prevent tuberculosis) on healthcare professionals, to verify the protection of the immunizer against Covid-19 as well. The ... Read more
15/10/2020 Ricardo Valverde As part of the celebrations of the 120th anniversary of the Oswaldo Cruz Foundation, the National Institute of Public Communication in Science and Technology (INCT-CPCT) has coordinated the survey How Brazilians see Fiocruz: a survey in 12 ... Read more
Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more
27/07/2020 Icict/Fiocruz Going back to school may represent an extra risk for more than 9.3 million Brazilians (4.4% of the overall population) who are elderly or adults (18 years and up) with chronic health conditions and at risk for Covid-19 ... Read more
Understanding the gendered dimensions of - COVID-19 - #InFocus
Watch the webinar in English
Follow the Fiocruz response and Brazilian actions and numbers regarding the COVID-19 pandemic.
Go to page
Available in English and Portuguese
The course presents general concepts of yellow fever, aimed at health professionals who work in primary healthcare. At the end of this course, you will be able to:
